1. Home
  2. ANIX vs ELTX Comparison

ANIX vs ELTX Comparison

Compare ANIX & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIX
  • ELTX
  • Stock Information
  • Founded
  • ANIX 1982
  • ELTX 2011
  • Country
  • ANIX United States
  • ELTX United States
  • Employees
  • ANIX N/A
  • ELTX N/A
  • Industry
  • ANIX Biotechnology: Pharmaceutical Preparations
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANIX Health Care
  • ELTX Health Care
  • Exchange
  • ANIX Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • ANIX 92.5M
  • ELTX 80.4M
  • IPO Year
  • ANIX 1987
  • ELTX 2021
  • Fundamental
  • Price
  • ANIX $2.88
  • ELTX $4.63
  • Analyst Decision
  • ANIX Strong Buy
  • ELTX Buy
  • Analyst Count
  • ANIX 1
  • ELTX 2
  • Target Price
  • ANIX $7.00
  • ELTX $10.00
  • AVG Volume (30 Days)
  • ANIX 142.4K
  • ELTX 73.5K
  • Earning Date
  • ANIX 09-04-2024
  • ELTX 08-09-2024
  • Dividend Yield
  • ANIX N/A
  • ELTX N/A
  • EPS Growth
  • ANIX N/A
  • ELTX N/A
  • EPS
  • ANIX N/A
  • ELTX N/A
  • Revenue
  • ANIX N/A
  • ELTX N/A
  • Revenue This Year
  • ANIX N/A
  • ELTX N/A
  • Revenue Next Year
  • ANIX N/A
  • ELTX N/A
  • P/E Ratio
  • ANIX N/A
  • ELTX N/A
  • Revenue Growth
  • ANIX N/A
  • ELTX N/A
  • 52 Week Low
  • ANIX $2.15
  • ELTX $2.96
  • 52 Week High
  • ANIX $5.13
  • ELTX $11.45
  • Technical
  • Relative Strength Index (RSI)
  • ANIX 53.23
  • ELTX 42.87
  • Support Level
  • ANIX $2.71
  • ELTX $4.12
  • Resistance Level
  • ANIX $3.44
  • ELTX $4.99
  • Average True Range (ATR)
  • ANIX 0.24
  • ELTX 0.52
  • MACD
  • ANIX 0.02
  • ELTX 0.18
  • Stochastic Oscillator
  • ANIX 49.19
  • ELTX 84.19

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: